Tag: evidence-based practice
Counseling clients in the UK who found CBT unhelpful were interviewed about their experiences.
I am often contacted by organizations seeking help with documenting how their efforts make a statistically significant difference when it comes to their clients’ success. Let’s take a look at some of the essential aspects that must be considered for those seeking documentation of evidence-based treatment.
Researchers argue for plurality and diversity among psychotherapy approaches and question the perceived superiority of Cognitive Behavioral Therapy (CBT).
Attempts to bridge the gap between research and practice result in a family therapy approach which employs clients as co-researchers.
Meta-analytic study finds that psychodynamic therapy outcomes are equivalent to those of CBT and other empirically supported treatments.
In a recently published commentary in Psychiatric Times, Ronald Pies and Joseph Pierre made this assertion: Only clinicians, with an expertise in assessing the research literature, should be weighing in on the topic of the efficacy of psychiatric drugs. They wrote their commentary shortly after I had published on madinamerica “The Case Against Antipsychotics,” and it was clear they had me in their crosshairs.
Mental Health First Aid is designated as an evidence-based practice, but what does that really mean? All it means is that the program has gotten enough grant money to get some research that proves it meets its designated outcome criteria. This does not mean the real-life outcomes for the people involved, or for society, are desirable or helpful.
For a long time I have felt that there just isn’t a good enough and long enough study on the pros and cons of long-term antipsychotic treatment versus reduction and discontinuation in people who have psychotic disorders, including those who are classified as having schizophrenia. Moreover, there are increasing reasons to be worried about the effects of long-term treatment with antipsychotics. I put this case to the UK’s National Institute of Health Research recently, and proposed that they fund a trial to assess the long-term outcomes of a gradual programme of antipsychotic reduction compared with standard ‘maintenance treatment.’ The NIHR agreed that this was an important issue, and that a new trial was urgently needed. The RADAR (Research into Antipsychotic Discontinuation And Reduction) study officially started in January 2016.